Dalrada (DFCO) Removes Shell Company Status.

LIVE QUOTE SAN DIEGO, Nov. 6, 2020 SAN DIEGO , Nov. 6, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), announced that it has filed Form 8-A12b with the U.S....
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared effective by...
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price to $305 from $232D.A. Davidson raises...
Hapbee, Biotech Stock Review

Hapbee Technologies (HAPB): Updates and News Archive.

Recent Headlines UPDATED CONTINUOUSLY. June 4, 2021: Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO. May 27, 2021: Adding Hapbee Tech (HAPB,...
Hapbee, Biotech Stock Review

Hapbee (HAPB) Soars 136% the First Day of Trading!

LIVE QUOTE Subscribe here for upcoming report. Investors who participated in the recently closed Hapbee Technologies (HAPB) private placement in July at CDN $0.30 per share...
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch List.4. Dalrada (DFCO) $0.11, Cancer Screening Test...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee...
Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE This was admittedly a small test, with only 100 patients. But keep in mind in the first place, this isn't...
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million. https://youtu.be/fXwvdN4XnKU In 2012, the U.S. Preventive...

Latest article

Report: AI Powered Review on GeoVax (GOVX) $1.15

In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...

Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added to Watch List.

Biotech 12 Pack Watch List to be Released. In 2020, we Released the "Biotech 5 Pack" Which Later Grew to a 6 Pack, with a...

REPORT OpenWorld: The Contrarian’sCase for OPNW

Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some. LIVE QUOTE RECENT NEWS VerifyMe Reports Fourth Quarter...